KLP Kapitalforvaltning’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$392K Hold
11,800
– – ﹤0.01% 1590
2026
Q2
$438K Hold
11,800
– – ﹤0.01% 1560
2026
Q1
$399K Hold
11,800
– – ﹤0.01% 1527
2025
Q4
$321K Hold
11,800
– – ﹤0.01% 1633
2025
Q3
$474K Hold
11,800
– – ﹤0.01% 1424
2025
Q2
$392K Buy
11,800
+1,800
+18% +$54.6K ﹤0.01% 1473
2025
Q1
$293K Hold
10,000
– – ﹤0.01% 1571
2024
Q4
$329K Hold
10,000
– – ﹤0.01% 1598

Other funds holding AGIO

KLP Kapitalforvaltning's AGIO Position: Q3 2026 in Review

KLP Kapitalforvaltning held its Agios Pharmaceuticals (AGIO) position steady in Q3 2026 at 11,800 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

KLP Kapitalforvaltning first reported a position in AGIO in Q4 2024 and has held it in 8 quarters since. The position peaked at $474K in Q3 2025. 243 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • KLP Kapitalforvaltning held 11,800 shares of Agios Pharmaceuticals worth $392K as of Q3 2026.
  • KLP Kapitalforvaltning left its Agios Pharmaceuticals share count unchanged in Q3 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #1590 holding.
  • KLP Kapitalforvaltning first reported a position in Agios Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • KLP Kapitalforvaltning's Agios Pharmaceuticals position peaked at $474K in Q3 2025.
  • 243 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.